Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor

Neuropharmacology

Volumn 62, Issue 5-6, 2012, Pages 2024-2033

  Umathe, Sudhir N ^a   Manna, Shyamshree S S ^a   Jain, Nishant S ^b  

^a RTM NAGPUR UNIVERSITY   (India)

^b Maharashtra Industrial Development Corporation India   (India)

Author keywords

AM404; Anandamide; Capsazepine; CB 1 receptors; FAAH inhibitors; Obsessive compulsive disorder

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CAPSAICIN; CAPSAZEPINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; FLUOXETINE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; VANILLOID RECEPTOR 1;

ABNORMAL BEHAVIOR; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; COMPULSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG TARGETING; LOCOMOTION; MALE; MARBLE BURYING BEHAVIOR; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BENZAMIDES; CANNABINOIDS; CARBAMATES; MICE; MOTOR ACTIVITY; POLYUNSATURATED ALKAMIDES; TRPV CATION CHANNELS;

EID: 84857062956     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.12.030     Document Type: Article

References (62)

1. 1 knockout mice: involvement in the depressive-like phenotype Eur. Neuropsychopharmacol. 21 2011 11 22
2. M. Beltramo, N. Stella, A. Calignano, S.Y. Lin, A. Makriyannis, and D. Piomelli Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1997 1094 1097 (Pubitemid 27371630)
3. S. Bhattacharyya, and K. Chakraborty Glutamatergic dysfunction-newer targets for anti-obsessional drugs Recent Pat. CNS Drug Discov. 2 2007 47 55 (Pubitemid 46729090)
4. M. Bortolato, P. Campolongo, R.A. Mangieri, M.L. Scattoni, R. Frau, V. Trezza, G. La Rana, R. Russo, A. Calignano, G.L. Gessa, V. Cuomo, and D. Piomelli Anxiolytic like properties of the anandamide transport inhibitor AM404 Neuropsychopharmacology 31 2006 2652 2659 (Pubitemid 44764162)
5. C. Broekkamp, H.W. Rijk, D. Joly-Gelouin, and K.L. Lloyd Major tranquilizers can be distinguished from minor tranquillizers on the basis of effects on marble-burying behavior and swim-induced grooming in mice Eur. J. Pharmacol. 126 1986 223 229 (Pubitemid 16016552)
6. A.C. Campos, and F.S. Guimarães Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1517 1521
7. 1 receptors Behav. Pharmacol. 21 2010 353 358
8. L. Cristino, L. De Petrocellis, G. Pryce, D. Baker, V. Guglielmotti, and V. Di Marzo Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain Neuroscience 139 2006 1405 1415
9. E.H. Decloedt, and D.J. Stein Current trends in drug treatment of obsessive-compulsive disorder Neuropsychiatr. Dis. Treat. 6 2010 233 242
10. V. Di Marzo, I. Lastres-Becker, T. Bisogno, L. De Petrocellis, A. Milone, J.B. Davis, and J.J. Fernandez-Ruiz Hypolocomotor effects, in rats of capsaicin and two long chain capsaicin homologues Eur. J. Pharmacol. 420 2001 123 131 (Pubitemid 32537687)
11. N. Egashira, R. Okuno, S. Harada, M. Matsushita, K. Mishima, K. Iwasaki, R. Nishimura, R. Oishi, and M. Fujiwara Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder Eur. J. Pharmacol. 586 2008 164 170
12. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol. Rev. 83 2003 1017 1066 (Pubitemid 36828930)
13. 1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum J. Neurophysiol. 85 2001 468 471 (Pubitemid 32062158)
14. 1 receptor-mediated neurotransmission decreases marble burying behavior in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 434 438
15. 1-specific agents Behav. Pharmacol. 15 2004 299 304 (Pubitemid 39062560)
16. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Cannabinoid receptor localization in brain Proc. Natl. Acad. Sci. U.S.A. 87 1990 1932 1936
17. 1 receptor stimulation on a vanilloid VR1 receptor mediated response Cell. Mol. Life Sci. 60 2003 607 616 (Pubitemid 36459539)
18. 1 receptor activity elicits an antidepressant-like response in the rat forced swim test Eur. Neuropsychopharmacol. 15 2005 593 599 (Pubitemid 41587409)
19. 1 receptor inverse agonist AM251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats Behav. Brain Res. 193 2008 298 305
20. D.S. Husted, N.A. Shapira, and W.K. Goodman The neurocircuitry of obsessive-compulsive disorder and disgust Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 389 399
21. Y. Ichimaru, T. Egawa, and A. Sawa 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice Jpn. J. Pharmacol. 68 1995 65 70
22. D. Joel Current animal models of obsessive compulsive disorder: a critical review Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 374 388
23. 1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain Naunyn-Schmiedeberg's Arch. Pharmacol. 359 1999 466 470 (Pubitemid 29302618)
24. K. Kim, and D.Y. Lee Obsessive-compulsive disorder associated with a left orbitofrontal infarct J. Neuropsychiatry Clin. Neurosci. 14 2002 88 89
25. T. Londei, A.M. Valentini, and V.G. Leone Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour Behav. Brain Res. 94 1998 249 254 (Pubitemid 28352825)
26. S. Marinelli, V. Di Marzo, F. Florenzano, F. Fezza, M.T. Viscomi, M. van der Stelt, G. Bernardi, M. Molinari, M. Maccarrone, and N.B. Mercuri N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors Neuropsychopharmacology 32 2007 298 308 (Pubitemid 46106937)
27. S. Marinelli, T. Pascucci, G. Bernardi, S. Puglisi-Allegra, and N.B. Mercuri Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens Neuropsychopharmacology 30 2005 864 870 (Pubitemid 40570902)
28. R. Marsch, E. Foeller, G. Rammes, M. Bunck, M. Kossl, F. Holsboer, W. Zieglgänsberger, R. Landgraf, B. Lutz, and C.T. Wotjak Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice J. Neurosci. 27 2007 832 839 (Pubitemid 46174502)
29. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, M.G. Cascio, H. Hermann, J. Tang, C. Hofmann, W. Zieglgänsberger, V. Di Marzo, and B. Lutz The endogenous cannabinoid system controls extinction of aversive memories Nature 418 2002 530 534 (Pubitemid 34851398)
30. 1 cannabinoid receptors in emotional behaviour Psychopharmacology (Berl.) 159 2002 379 387 (Pubitemid 34143362)
31. D. Mataix-Cols, and O.A. van den Heuvel Common and distinct neural correlates of obsessive-compulsive and related disorders Psychiatr. Clin. North Am. 29 2006 391 410
32. E. Mezey, Z.E. Tóth, D.N. Cortright, M.K. Arzubi, J.E. Krause, R. Elde, A. Guo, P.M. Blumberg, and A. Szallasi Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc. Natl. Acad. Sci. U.S.A. 97 2000 3655 3660 (Pubitemid 30183358)
33. V. Micale, L. Cristino, A. Tamburella, S. Petrosino, G.M. Leggio, F. Drago, and V. Di Marzo Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels Neuropsychopharmacology 34 2009 593 606
34. V.A. Mitchell, R. Greenwood, A. Jayamanne, and C.W. Vaughan Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models Clin. Exp. Pharmacol. Physiol. 34 2007 1186 1190 (Pubitemid 47416352)
35. K.R. Muller-Vahl, U. Schneider, A. Koblenz, M. Jobges, H. Kolbe, T. Daldrup, and H.M. Emrich Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial Pharmacopsychiatry 35 2002 57 61 (Pubitemid 34293234)
36. 1 receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 361 2000 19 24 (Pubitemid 30064649)
37. K. Njung'e, and S.L. Handley Evaluation of marble-burying behavior as a model of anxiety Pharmacol. Biochem. Behav. 38 1991 63 67
38. G. Paxinos, and R.B.J. Franklin The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
39. 1 receptors Life Sci. 76 2005 1307 1324
40. D. Piomelli, G. Tarzia, A. Duranti, A. Tontini, M. Mor, T.R. Compton, O. Dasse, E.P. Monaghan, J.A. Parrott, and D. Putman Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597) CNS Drug Rev. 12 2006 21 38 (Pubitemid 44133578)
41. C. Pittenger, J.H. Krystal, and V. Coric Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder NeuroRx 3 2006 69 81 (Pubitemid 43276634)
42. J. Radua, and D. Mataix-Cols Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder Br. J. Psychiatry 195 2009 393 402
43. S.A. Rasmussen, and J.L. Eisen The epidemiology and clinical features of obsessive compulsive disorder Psychiatr. Clin. North Am. 15 1992 743 758 (Pubitemid 23032171)
44. S.M. Rawls, Z. Ding, and A. Cowan Role of TRPV1 and cannabinoid receptors in AM404-evoked hypothermia in rats Pharmacol. Biochem. Behav. 83 2006 508 516 (Pubitemid 43817120)
45. J.C. Roberts, J.B. Davis, and C.D. Benham [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution Brain Res. 995 2004 176 183 (Pubitemid 37522018)
46. R.A. Ross Anandamide and vanilloid TRPV1 receptors Br. J. Pharmacol. 140 2003 790 801 (Pubitemid 37464060)
47. R.A. Ross, T.M. Gibson, H.C. Brockie, M. Leslie, G. Pashmi, S.J. Craib, V. Di Marzo, and R.G. Pertwee Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens Br. J. Pharmacol. 132 2001 631 640 (Pubitemid 32165178)
48. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Vigano, E. Marras, S. Petrosino, G. Perletti, M. Maccarrone, V. Di Marzo, and D. Parolaro Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb. Cortex 18 2008 1292 1301 (Pubitemid 351769783)
49. T. Sasamura, M. Sasaki, C. Tohda, and Y. Kuraishi Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus Neuroreport 9 1998 2045 2048 (Pubitemid 28300564)
50. Y. Sasson, J. Zohar, M. Chopra, M. Lustig, I. Iancu, and T. Hendler Epidemiology of obsessive-compulsive disorder: a world view J. Clin. Psychiatry 58 1997 7 10 (Pubitemid 27516504)
51. M. Shen, T.M. Piser, V.S. Seybold, and S.A. Thayer Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures J. Neurosci. 16 1996 4322 4334 (Pubitemid 26243028)
52. D.M. Sheppard, J.L. Bradshaw, R. Purcell, and C. Pantelis Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? Clin. Psychol. Rev. 19 1999 531 552 (Pubitemid 29294035)
53. K. Starowicz, L. Cristino, and V. Di Marzo TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications Curr. Pharm. Des. 14 2008 42 54 (Pubitemid 351266983)
54. K. Starowicz, S. Nigam, and V. Di Marzo Biochemistry and pharmacology of endovanilloids Pharmacol. Ther. 114 2007 13 33 (Pubitemid 46498161)
55. E. Sulcova, R. Mechoulam, and E. Fride Biphasic effects of anandamide Pharmacol. Biochem. Behav. 59 1998 347 352 (Pubitemid 28072727)
56. A. Thomas, A. Burant, N. Bui, D. Graham, L.A. Yuva-Paylor, and R. Paylor Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety Psychopharmacology (Berl.) 204 2009 361 373
57. A. Tóth, J. Boczán, N. Kedei, E. Lizanecz, Z. Bagi, Z. Papp, I. Edes, L. Csiba, and P.M. Blumberg Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain Brain Res. Mol. Brain Res. 135 2005 162 168 (Pubitemid 40602409)
58. S.N. Umathe, J.M. Vaghasiya, N.S. Jain, and P.V. Dixit Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1161 1166
59. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol. Biochem. Behav. 81 2005 331 342 (Pubitemid 40807131)
60. J.M. Welch, J. Lu, R.M. Rodriguiz, N.C. Trotta, J. Peca, J.D. Ding, C. Feliciano, M. Chen, J.P. Adams, J. Luo, S.M. Dudek, R.J. Weinberg, N. Calakos, W.C. Wetsel, and G. Feng Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice Nature 448 2007 894 900 (Pubitemid 47312780)
61. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
62. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sørgrd, V. Di Marzo, D. Julius, and E.D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457 (Pubitemid 29361798)